These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24466071)

  • 1. The effect of intra-arterial angiotensin II on the hepatic tumor to non-tumor blood flow ratio for radioembolization: a systematic review.
    van den Hoven AF; Smits ML; Rosenbaum CE; Verkooijen HM; van den Bosch MA; Lam MG
    PLoS One; 2014; 9(1):e86394. PubMed ID: 24466071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An effect of the intra-arterial infusion of angiotensin II in the chemotherapy of human hepatic cancer].
    Sasaki Y; Imaoka S; Ohigashi H; Ishikawa O; Koyama H; Iwanaga T; Hasegawa Y; Nakano S; Fujita M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1456-63. PubMed ID: 3729462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in distribution of hepatic blood flow induced by intra-arterial infusion of angiotensin II in human hepatic cancer.
    Sasaki Y; Imaoka S; Hasegawa Y; Nakano S; Ishikawa O; Ohigashi H; Taniguchi K; Koyama H; Iwanaga T; Terasawa T
    Cancer; 1985 Jan; 55(2):311-6. PubMed ID: 2981143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic arterial haemodynamics changes following intra-arterial angiotensin II infusion: duplex/colour Doppler sonography.
    Leen E; Angerson WJ; Warren H; Goldberg JA; Leiberman DP; Cooke TG; McArdle CS
    Clin Radiol; 1993 May; 47(5):321-4. PubMed ID: 8508593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of angiotensin II on tumor blood flow and the delivery of microparticulate cytotoxic drugs.
    Kerr DJ; Goldberg JA; Anderson JR; Wilmott N; Whatelely AT; McArdle CS; Mckillop J
    EXS; 1992; 61():339-45. PubMed ID: 1617236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion.
    Leen E; Angerson WJ; Warren HW; Goldberg JA; Sutherland GR; Cooke TG; McArdle CS
    Br J Cancer; 1993 Jun; 67(6):1381-4. PubMed ID: 8512823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous angiotensin II infusion increases tumour: normal blood flow ratio in colo-rectal liver metastases.
    Burke D; Davies MM; Zweit J; Flower MA; Ott RJ; Dworkin MJ; Glover C; McCready VR; Carnochan P; Allen-Mersh TG
    Br J Cancer; 2001 Nov; 85(11):1640-5. PubMed ID: 11742481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes.
    Piana PM; Bar V; Doyle L; Anne R; Sato T; Eschelman DJ; McCann JW; Gonsalves CF; Brown DB
    HPB (Oxford); 2014 Apr; 16(4):336-41. PubMed ID: 23782387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential intra-arterial infusion of 90Y-resin microspheres and mitomycin C in chemo refractory liver metastatic breast cancer patients: a single centre pilot study.
    Aarts BM; Klompenhouwer EG; Dresen RC; Deroose CMALO; Beets-Tan RGH; Punie K; Neven P; Wildiers H; Maleux G
    Radiol Oncol; 2020 Jan; 54(1):33-39. PubMed ID: 31967966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy.
    Hendlisz A; Van den Eynde M; Peeters M; Maleux G; Lambert B; Vannoote J; De Keukeleire K; Verslype C; Defreyne L; Van Cutsem E; Delatte P; Delaunoit T; Personeni N; Paesmans M; Van Laethem JL; Flamen P
    J Clin Oncol; 2010 Aug; 28(23):3687-94. PubMed ID: 20567019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic Flow Redistribution is Feasible in Patients with Hepatic Malignancies Undergoing Same-Day Work-Up Angiography and Yttrium-90 Microsphere Radioembolization.
    Ezponda A; Rodríguez-Fraile M; Morales M; Vivas I; De La Torre M; Sangro B; Bilbao JI
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):987-995. PubMed ID: 31848672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of liver tumor blood flow with hepatic arterial epinephrine: a SPECT study.
    Andrews JC; Walker-Andrews SC; Juni JE; Warber S; Ensminger WD
    Radiology; 1989 Dec; 173(3):645-7. PubMed ID: 2813766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.
    Brown DB; Nikolic B; Covey AM; Nutting CW; Saad WE; Salem R; Sofocleous CT; Sze DY;
    J Vasc Interv Radiol; 2012 Mar; 23(3):287-94. PubMed ID: 22284821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hepatic hemodynamic changes in liver cancer patients during intrahepatic arterial angiotensin II infusion induced hypertension and chemoembolization].
    Jiang XQ; Yin GF; Lu XX
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):647-9. PubMed ID: 7774400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.
    Kao YH; Hock Tan AE; Burgmans MC; Irani FG; Khoo LS; Gong Lo RH; Tay KH; Tan BS; Hoe Chow PK; Eng Ng DC; Whatt Goh AS
    J Nucl Med; 2012 Apr; 53(4):559-66. PubMed ID: 22343503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yttrium-90 radioembolization for the treatment of chemorefractory colorectal liver metastases: Technical results, clinical outcome and factors potentially influencing survival.
    Maleux G; Deroose C; Laenen A; Verslype C; Heye S; Haustermans K; De Hertogh G; Sagaert X; Topal B; Aerts R; Prenen H; Vanbeckevoort D; Vandecaveye V; Van Cutsem E
    Acta Oncol; 2016; 55(4):486-95. PubMed ID: 26625262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolization of hepatic arterial branches to simplify hepatic blood flow before yttrium 90 radioembolization: a useful technique in the presence of challenging anatomy.
    Karunanithy N; Gordon F; Hodolic M; Al-Nahhas A; Wasan HS; Habib N; Tait NP
    Cardiovasc Intervent Radiol; 2011 Apr; 34(2):287-94. PubMed ID: 20700593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.